-
-
-
-
-
-
-
Todos Medical Announces Data Lock in Tollovir Phase 2 Clinical Trial for the Treatment of Hospitalized COVID-19 Patients
-
-
-
-
-
-
-
Todos Medical Announces New cPass Neutralizing Antibody Testing Reference Lab Agreement for CLIA/CAP Lab Provista with Physician Group in 40 States
-
-
-
-
-
-
-
Update: Todos Medical Reports Third Quarter 2021 Business and Financial Results
-
-
-
-
-
-
-
Todos Medical Announces Positive Data in Hospitalized and Outpatient Setting for TolloTestâ„¢, a Novel SARS-CoV-2 3CL Protease Biomarker Assay
-
-
-
-
-
-
-
UPDATE: Todos Medical Announces 90-Day Moratorium on Conversions of Convertible Notes and Lockup of Common Stock Sales with Convertible Note Holders
-
-
-
-
-
-
-
Todos Medical Provides End of Second Quarter 2021 Corporate Update
-
-
-
-
-
-
-
Todos Medical Provides Corporate Update
-
1,157,715 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

